Stock GRANULES GRANULES INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:47 2024-04-19 am EDT 		5-day change 1st Jan Change
411.4 INR -0.80% Intraday chart for Granules India Limited -2.49% +1.46%
Apr. 15 Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit MT
Apr. 03 Granules India Unit Gets VAI Status for Virginia Facility MT

Business Summary

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

Number of employees: 3,650

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Products
99.7 %
37,272 99.0 % 44,963 99.7 % +20.64%
Other
0.3 %
377 1.0 % 156 0.3 % -58.73%

Sales per region

INR in Million2022Weight2023Weight Delta
International
93.6 %
27,821 85.9 % 42,224 93.6 % +51.77%
India
6.4 %
4,563 14.1 % 2,895 6.4 % -36.55%

Managers

Managers TitleAgeSince
Kandiraju Venkata S. Rao CEO
 Chief Executive Officer 60 22-01-04
Krishna Prasad Chigurupati CEO
 Chief Executive Officer 69 91-03-17
Mukesh Surana DFI
 Director of Finance/CFO 44 22-12-29
Manikandan Ramalingam CTO
 Chief Tech/Sci/R&D Officer - -
P.V. Srinivas CTO
 Chief Tech/Sci/R&D Officer - -
GSR Prasad COO
 Chief Operating Officer - 16-12-31
Chaitanya Tummala CMP
 Compliance Officer - -
Sanjay Kumar PRN
 Corporate Officer/Principal - 21-11-30

Members of the board

Members of the board TitleAgeSince
Basava Sankara Rao Kolli BRD
 Director/Board Member 70 13-02-18
Saumen Chakraborty BRD
 Director/Board Member 62 21-12-12
Rajiv Pritidas Kakodkar BRD
 Director/Board Member 67 Feb. 19
Krishna Prasad Chigurupati CEO
 Chief Executive Officer 69 91-03-17
Kapil Kewal Mehan BRD
 Director/Board Member 65 23-05-15
Harsha Chigurupati BRD
 Director/Board Member 40 04-12-31
Uma Devi Chigurupati BRD
 Director/Board Member 64 12-05-30
Priyanka Chigurupati BRD
 Director/Board Member - Jan. 22
Sucharitha Rao Palepu BRD
 Director/Board Member - 21-12-21
Kandiraju Venkata S. Rao CEO
 Chief Executive Officer 60 22-01-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 242,368,716 132,027,237 ( 54.47 %) 0 54.47 %

Shareholders

NameEquities%Valuation
Krishna Prasad Chigurupati
34.78 %
84,299,111 34.78 % 435 M ₹
Uma Devi Chigurupati
3.813 %
9,240,761 3.813 % 48 M ₹
Life Insurance Corporation of India (Investment Portfolio)
2.304 %
5,584,453 2.304 % 29 M ₹
quant Money Managers Ltd.
2.202 %
5,337,894 2.202 % 28 M ₹
Tyche Investments Pvt Ltd.
1.466 %
3,552,557 1.466 % 18 M ₹
Aditya Birla Sun Life Trustee Pvt Ltd.
1.272 %
3,083,758 1.272 % 16 M ₹
Aditya Birla Sun Life Amc Ltd. (Investment Management)
1.253 %
3,037,323 1.253 % 16 M ₹
Basava Sankara Rao Kolli
1.207 %
2,926,530 1.207 % 15 M ₹
Norges Bank Investment Management
1.151 %
2,789,094 1.151 % 14 M ₹
Mahima Stocks Pvt Ltd.
1.128 %
2,734,695 1.128 % 14 M ₹

Company contact information

Granules India Ltd.

My Home Hub 2nd Floor, 3rd Block

500081, Hyderabad

+91 40 6904 3500

http://www.granulesindia.com
address Granules India Limited(GRANULES)

Group companies

NameCategory and Sector
Granules Pharmaceuticals, Inc.
Logo Granules Pharmaceuticals, Inc.

Granules Pharmaceuticals, Inc.

Pharmaceuticals: MajorHealth Technology

Granules Pharmaceuticals, Inc. develops and manufactures pharmaceutical formulations. The firm manufactures tablets, pharmaceutical formulation intermediates and active pharmaceutical ingredients. The company is headquartered in Chantilly, VA.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Granules India Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
415.4 INR
Average target price
483.4 INR
Spread / Average Target
+16.36%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.58% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 317B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.96% 211B
NOVARTIS AG Stock Novartis AG
-0.41% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GRANULES Stock
  4. GRANULES Stock
  5. Company Granules India Limited